← Browse by Condition
Medical Condition
prostate hyperplasia
Total Trials
3
Recruiting Now
3
Trial Phases
Various
ClinicalMetric tracks all active clinical trials for prostate hyperplasia sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Top Sponsors
1 trial
1 trial
1 trial
NCT06834152
Recruiting
Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer (X-SMILE)
Enrollment
75 pts
Location
Germany, Switzerland
Sponsor
University of Zurich
NCT06649357
Recruiting
Comparison Between Bipolar Transurethral Resection of the Prostate and Moses Assisted Holmium Laser Enucleation of the Prostate
Enrollment
130 pts
Location
Spain
Sponsor
Fundacio Puigvert
NCT05443451
Recruiting
BETTY: BEnign Prostatic Hyperplasia Transperineal Targeted Microwave therapY
Enrollment
12 pts
Location
Hong Kong
Sponsor
Chinese University of Hong Kon...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology